Join
1
Keep up to date with the genomic profiling in precision oncology
2
Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment
3
New McDonald Criteria Expand MS Diagnoses: ACTRIMS 2025
4
Investigating FDA Reports of Tirzepatide-Thyroid Cancer Connection
5
Bacteria Found to Drive Prostate Cancer Progression
How Inflammation Shapes Human Ageing and Health
SGLT2 Inhibitors Reduce Hyperkalemia Risk in RAASi Use
Exploring JAK Inhibitors for Safer, More Effective Vitiligo Treatment
Semaglutide Shows Promise in Treating MASH and Liver Fibrosis
BMS names Cari Gallman as new General Counsel
EMJ’s Spring journal is here
Mirikizumab Shows Promise in Treating Inflammatory Bowel Disease
Parkinson’s Risk May Rise Near Golf Courses
Hema Now: Episode 16: A Journey Through Leukaemia Research
EASL 2025 – NHS Opt-Out Testing Detects Hepatitis
Metagenomics Breakthrough Saves Woman’s Eyesight After Rare Infection
Calcified Lesions: AI-Driven μQFR Offers Viable Alternative to Fractional Flow Reserve
CMV After Transplant: Could Targeted T-Cell Therapy Change the Game?
Dual Index Approach Enhances Detection of Functional Decline in Patients on Haemodialysis
AI-Powered Pathology Tool Improves Pediatric Sarcoma Diagnosis: AACR 2025
Persistent Lung and Heart Inflammation Found in Majority of Long COVID Patients
Cervical Cancer Study Supports De-escalating Chemotherapy
Lactation Support Lacking for ICU Mothers, Study Finds
Improving Bedside Nursing With ISBAR Communication
Adequate mitomycin C can effectively reduce recurrence and progression in patients with IR NMIBC – the value of maintenance therapy*
